BioPharma Dive - Latest News

Lexeo to help launch spinout around RNA drugs for the heart

Backed by Perceptive Xontogeny Venture Funds and venBio Partners, the new biotech will make genetic medicines that don’t rely on viral vectors.

Jun 24, 2025 - 20:25
 0
Lexeo to help launch spinout around RNA drugs for the heart

Backed by Perceptive Xontogeny Venture Funds and venBio Partners, the new biotech will make genetic medicines that don’t rely on viral vectors.

Read More

Tags:

Previous Article

Biotech Firm Cellugy Scores $9.25M Grant To Replace Petrochemicals In Beauty Pro...

Next Article

STAT+: Regeneron seeks to revamp the controversial relationships between pharma ...

Related Posts

Prime Medicine claims ‘proof of concept,’ but lays off staff in pivot

Prime Medicine claims ‘proof of concept,’ but lays off ...

May 19, 2025  0

Merck claims study success with PCSK9 cholesterol pill

Merck claims study success with PCSK9 cholesterol pill

Jun 9, 2025  0

Otsuka tops Vera with kidney drug data; Regenxbio sinks on Duchenne update

Otsuka tops Vera with kidney drug data; Regenxbio sinks...

Jun 6, 2025  0